Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC

NCT06274294 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Bowel Diseases

Interventions

DRUG: CT-P13

Sponsor

CMC Ambroise Paré

Collaborators

[object Object]
[object Object]